High-dose omeprazole by mouth for serious ulcer bleeding
Part of Digestive system clinical trials.
This trial tests whether taking a high dose of omeprazole by mouth can help control bleeding from a peptic ulcer that looks high-risk on endoscopy. It may be aimed at lowering the chance of bleeding again after your procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your endoscopy showed a peptic ulcer with high-risk bleeding signs (spurt, ooze, or a visible vessel)
- You are willing to participate in the study
- You are not pregnant and not breastfeeding
- Your bleeding is from a peptic ulcer—not from other causes like tears, varices, or erosions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares an IV “acid-suppressing” medicine (PPI infusion) with acid pills (oral PPIs) after doctors treat a bleeding peptic ulcer endoscopically. It may help prevent re-bleeding by keeping stomach acid low while the ulcer heals.
This trial tests whether omeprazole (a stomach acid reducer) can help prevent stomach bleeding in older adults who are taking blood thinners for a newly diagnosed blood clot. It may be a good fit if you are 65 or older and starting blood thinners for a clot.
This trial studies medicines to help stop bleeding from coming back after you’ve had an “idiopathic” stomach/upper gut ulcer bleed. It may help by reducing ulcer re-bleeding risk in people who don’t have common causes like H. pylori or common ulcer-triggering drugs.
This trial tests whether a common acid-reducing medicine (a proton pump inhibitor) helps people with cirrhosis who are having bleeding from enlarged veins in the esophagus. The goal is to see if it improves outcomes after emergency treatment.
This trial tests whether proton pump inhibitors (PPIs) can help people with cirrhosis who are hospitalized for variceal bleeding. It looks at whether PPIs reduce complications during the hospital stay.
This trial tests whether a newer drug, tegoprazan, works as well as the standard drug lansoprazole for healing bleeding ulcers in the stomach or small intestine. You will get one of these drugs for 14 days and have a follow-up endoscopy to check healing.
Hear when a new GI Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.